Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hizentra® in Inflammatory Neuropathies - pHeNIx Study

NCT04672733 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT04672733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04672733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hizentra® in Inflammatory Neuropathies - pHeNIx Study
Lead sponsor
CSL Behring
Phase
Observational
Overall status
Recruiting
Start date
June 10, 2022
Completion date
December 31, 2027
Enrollment
100 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammatory demyelinating polyneuropathy